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Table 2
Association of atrophic knee OA with any progression of JSN and cartilage loss, compared to non-atrophic OA knees using both (radiographic and MRI) deﬁnitions of atrophic
and non-atrophic OA.
OA phenotype (Radiographic deﬁnition) Absence of progression of JSN Any progression of JSN Adjusted odds ratio
OR (95%CI) p-value
Non-atrophic OA 224/373 (60%) 149/373 (40%) 1.0 (ref)
Atrophic OA 54/77 (70%) 23/77 (3096) 0.6 (0.4, 1.0) 0.06
OA phenotype (Radiographic deﬁnition) Absence of progression of cartilage loss Any progression of cartilage loss Adjusted odds ratio
OR (95%CI) p-value
Non-atrophic OA 171/373 (46%) 202/373 (54%) 1.0 (ref) –
Atrophic OA 45/77 (58%) 32/77 (42%) 0.6 (0.3, 1.0) 0.04
OA Phenotype (MRI Deﬁnition)
Non-atrophic OA
Absence of Progression of JSN Any Progression of JSN Adjusted Odds Ratio
OR (95%CI) p-value
248/400 (62%) 152/450 (38%) 1.0 (ref) –
Atrophic OA 30/50 (60%) 20/50 (40%) 1.2 (0.7, 2.3) 0.53
OA Phenotype (MRI Deﬁnition) Absence of Progression of Cartilage Loss Any Progression of Cartilage Loss Adjusted Odds Ratio
OR (95%CI) p-value
Non-atrophic OA 187/400 (47%) 213/400(53%) 1.0 (ref) –
Atrophic OA 29/50 (58%) 21/50 (4296) 0.7 (0.4,1.3) 0.24
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A69of up to one OARSI grade in at least one compartment), and fast pro-
gression (an increase of more than one OARSI grade in at least one
compartment). Regarding progression of cartilage loss on MRI from
baseline to FU, three groups were deﬁned: no progression (same
WORMS grade in all ten subregions), slow (an increase up to one
WORMS grade, including within-grade increase, in at least one of the
ten subregions), and fast progression (an increase of more than one
WORMS grade in at least one of the ten subregions). Co-variance
analysis was performed to test if there were differences between
atrophic vs. non-atrophic knee OA phenotypes, using both (radiographs
and MRI) deﬁnitions, regarding no progression, slow, and fast pro-
gression of JSN and cartilage loss. Logistic regression analysis with
generalized estimated equations was performed to assess the associa-
tion of atrophic knee OA with any progression of JSN and cartilage loss,
compared to non-atrophic OA knees (reference group). The results were
adjusted for age, gender, body mass index, tibiofemoral malalignment,
progression of meniscal damage and extrusion.
Results: A total of 450 knees from 398 participants were included.
Using the radiographic deﬁnition, therewere 77 (17.1%) atrophic OA and
373 (82.9%) non-atrophic OA knees at baseline. Using the MRI deﬁ-
nition, there were 50 (11.1%) atrophic OA and 400 (88.9%) non-atrophic
OA knees. There were no signiﬁcant differences between both groups
(atrophic vs. non-atrophic) regarding fast progression of JSN or cartilage
damage (Table 1). Logistic regression analysis using both deﬁnitions
showed that the atrophic phenotype of knee OA was not at increased
risk for progression of disease compared to the non-atrophic phenotype
(Table 2). Using the radiographic deﬁnition, a modest protective effect
against progression of MRI cartilage loss was demonstrated for atrophic
OA knees when compared to the non-atrophic group (OR ¼ 0.6 (95%CI
0.3, 1.0); p¼0.04).
Conclusions: Based on these results, the atrophic phenotype of knee OA
does not predispose OA joints to more rapid progression compared to
non-atrophic OA. This ﬁnding might be of potential relevance for eli-
gibility of participants with atrophic knee OA in aNGF programswho are
commonly excluded due to potential increased risk for rapid pro-
gressive OA.
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CROSS-SECTINAL AND LONGITUDINAL ASSOCIATIONS BETWEEN
SERUM LEVELS OF HIGH SENSITIVITY C-REACTIVE PROTEIN,
RESISTIN AND KNEE BONE MARROW LESIONS IN PATIENTS WITH
KNEE OSTEOARTHRITIS
Z. Zhu y, X. Jing y, B. Wang z, A. Wluka z, B. Antony y, L. Laslett y,
T. Winzenberg y, F. Cicuttini z, G. Jones y, C. Ding y. yMenzies Inst. for
Med. Res., Hobart, Australia; zDept. of Epidemiology and Preventive
Med., Monash Univ., Melbourne, Melbourne, Australia
Purpose: Low-grade inﬂammationmayplaya role in osteoarthritis (OA).
Although some studies reported that inﬂammatorymarkers such as high
sensitivity C-reactiveprotein (hs-CRP)were increased inOA, theﬁndings
for associations between hs-CRP and OA are inconsistent. The link
between serum levels of hs-CRP and bone marrow lesions (BMLs) in OApatientshas not been explored., Similarly, the ﬁndings for the associa-
tions between resistin and OA are controversial and little is known if
resistin is associated with BMLs. The aims of this study were, therefore,
to describe the association between serum levels of hs-CRP, resistin and
BMLs cross sectionally and longitudinally in patients with knee OA.
Methods: A total of 188 patients (mean 63 years, range 50-79, female
53%) with symptomatic knee OA were selected from a randomised
placebo controlled clinical trial studying the effect of vitamin D sup-
plementation on OA. Serum levels of hs-CRP and resistin were tested at
baseline and 24 months later using enzyme-linked immunosorbent
assay (ELISA). T2 weighted fat-supressed fast spin echo magnetic res-
onance imaging (MRI) was performed at baseline and 24 months to
assess compartmental and total knee BMLs scores and their changes
using modiﬁed Whole-Organ MRI Score system (WORMS). Linear or
logistic regression analyses were used to determine the association of
baseline hs-CRP and resistin with total knee BMLs as well as changes or
increases in BMLs before and after adjustment for age, sex, BMI, treat-
ment (vitamin D / placebo) and CRP / resistin as appropriate.
Results: At baseline, quartiles of serum level of hs-CRP were associated
with total knee bonemarrow lesions in multivariable analyses (OR: 1.45
per quartile, 95% CI: 1.01, 2.09). Serum levels of resistin were associated
with total knee BMLs (b:0.04 per ng/ml, 95% CI: 0.01, 0.08). Longitudi-
nally, quartiles of serum levels of hs-CRP predicted increases in total
knee BMLs (OR: 1.51 per quartile, 95% CI: 1.08, 2.12; Figure 1), and
changes in serum levels of hs-CRP were associated with changes in total
knee BMLs (b: 0.09, 95% CI: 0.04, 0.34). Baseline resistin levels were not
signiﬁcantly associated with change in total BMLs. Change in serum
levels of resistin were only associated with changes in lateral tibiofe-
moral BMLs (b: 0.16, 95%CI: 0.01, 0.05) and not total knee BMLs (b: 1.01,
95%CI: 0.97, 1.04).
Conclusions: This is the ﬁrst study to report that serum levels of hs-CRP
are associated with total knee BMLs and predict worsening knee BMLs
over 2 years in patients with knee OA, suggesting inﬂammatory
involvement in the pathogenesis of BMLs. Serum resistin levels are
associated with BMLs in knee OA, but the causal relationship is
unknown.
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IDENTIFICATION OF AN INFLAMMATORY PHENOTYPE WITH HIGHER
LIKELIHOOD OF PROGRESSION IN OA: ANALYSIS OF WOMAC PAIN
SUB-QUESTIONS, C3M AND U-CTX-II FROM TWO PHASE 3
RANDOMIZED CLINICAL TRIALS WITH TREATMENT OF
SYMPTOMATIC KNEE OSTEOARTHRITIS
A.C. Bay-Jensen y, I. Byrjalsen y, K. Musa y, A. Bihlet y, P. Alexandersen z,
J.R. Andersen y, B.J. Riis y, C. Christiansen y, M.A. Karsdal y. ,
CSMC021C2301/2 investigatorsyNordic BioSci. A/S, Herlev, Denmark;
zCCBR A/S, Vejle, Denmark
Purpose: There are three main tissues remodeled as part of osteo-
arthritis (OA); cartilage, bone and the synovial membrane, which may
represent separate phenotypes that needs to be treated differently.
Recent data has shown that type II collagen degradation (CTX-II) is a
biomarker of cartilage and subchondral turnover. C3M is a biomarker of
synovial inﬂammation and turnover. It is estimated that about 10-30%
of OA patients have synovitis. The aim of the study was identify dif-
ferent subtypes of OA related to progression.
Methods: Fasting serum (n¼767) and urine (n¼620) samples were
collected at baseline from patients with painful knee OA participating in
the placebo arms of two phase III RCTs (NCT00486434 and
NCT00704847). Serum C3M (MMP-derived type III collagen neo-epit-
ope [Nordic Bioscience, Denmark]) and creatinine-corrected urinary
CTX-II (type II collagen C-terminal telopeptide [IDS PLC, United King-
dom]) were measured. The relationship between the biomarkers and
the 5 WOMAC pain subscale questions of the baseline-reported
WOMAC pain level, using the sum of target and non-target knee, were
analyzed: A; during walking on a ﬂat surface, B; using stairs (up or
down), C; at night while in bed, D; sitting or lying and E; while standing.
Joint space width was analyzed at baseline and after 24month. The data
were analyzed by Spearman’s correlations on log-transformed data and
by backward multiple regression analysis, where WOMAC or radio-
graphic scores were set as the dependent variable and biomarkers, age,
gender and BMI as covariates.
Results: Levels of CTX-II signiﬁcantly correlated withWOMACwith all 5
sub-questions (p<0.01), while level of C3M was correlated with ques-
tion B and E (p<0.05). When adjusting for age, BMI, and gender, CTX-II
remained signiﬁcantly associated with all sub-questions: A) r¼0.20,
p<0.0001; B) r¼0.16, p¼0.0005; C) r¼0.11, p¼0.017; D) r¼0.13,
p¼0.0046; and E) r¼0.17, p¼0.0002. C3M became non-signiﬁcant; B)
r¼0.08, p¼0.063 and E) r¼0.08, p¼0.069. CTX-II was signiﬁcantly cor-
related to the mean JSW of the two knees (r¼-0.17, p<0.0001), whereas
C3M was signiﬁcantly correlated to joint space narrowing of the target
knee (r¼0.11, p¼0.013).
Conclusions: Diagnostically, urinary CTX-II was associated with all
types of pain. Most prominent with WOMAC sub-question A, walking
on a ﬂat surface, which may indicate that CTX-II is related to pain
coming from continuous skeletal load - supported by the strong cor-
relation with JSW and previous data suggestion origins of subchondral
bone turnover and articular cartilage. C3M, which are released in syn-
ovitis, was weakly correlated with B and E, using stairs and standing
still, respectively. C3M was correlated to progression indicating that
patients with elevated C3M and consequently synovial inﬂammation
had a higher likelihood of being a progressor. These biomarkers may
assist in identiﬁcation of the inﬂammation driven OA phenotype, which
needs to be treated different than non-inﬂammatory OA.
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IMPROVED PHENOTYPE DEFINITIONS OF OA IN GENETIC
ASSOCIATION STUDIES HIGHLIGHT A STRUCTURAL ROLE FOR A
COMMON VARIANT IN LRCH1
K. Panoutsopoulou y, S. Thiagarajah z, A.G. Day-Williams y,x,
L. Southam y, arcOGEN ConsortiumM. Doherty k, E. Zeggini y,
J. Wilkinson z. yWellcome Trust Sanger Inst., Hinxton, United Kingdom;
zUniv. of Shefﬁeld, Shefﬁeld, United Kingdom; xBiogen Idec, Cambridge,
MA, USA; kUniv. of Nottingham, Nottingham, United Kingdom
Purpose: Osteoarthritis (OA) has a strong genetic component but the
success of previous genetic association studies has been restricted due
to insufﬁcient sample sizes and phenotype heterogeneity. Differences in
ascertainment criteria along with the highly heterogeneous clinical
manifestations of OA have been proposed as likely factors behind the
paucity of replication for genetic determinants of OA. The aim of our
study is to identify hip OA susceptibility variants by examining a set ofmore homogeneous, radiographically-derived OA endophenotypes
relating to speciﬁc anatomic pattern of joint involvement.
Methods: Hip OA subjects comprised in total 2,118 unrelated individuals
of European ancestry from the arcOGEN genome-wide association study
(GWAS). Inclusion criteriawere radiographic evidence of hip OA (Kellgren
Lawrence (KL)  2) and secondly, a set of minimum radiographic
requirements deﬁned as an antero-posterior (AP) view of the degenerate
hip joint. Hip OA pattern was classiﬁed using standard photographic
atlases as superior, axial, medial and concentric joint space narrowing.
1,817 cases had GWAS data on Illumina 610k and 301 cases had GWAS
data on the HumanOmniExpress platform. We used 6,500 population-
based, publically-available controls from the UK. Following 1000
Genomes-based imputation and stringent quality control we carried out
association analyses at ~7million variants using the score test under an
additive model and meta-analyses with the ﬁxed-effects model. We car-
ried out 2 types of association analyses: GWAS meta-analysis within OA
cases by comparing i) hip OA cases characterised by axial/medial femoral
head migration vs. all other hip OA cases and conversely hip OA cases
characterised by superior femoral head migration vs. all other hip OA
cases; and ii) GWAS of 1,817 hip OA cases stratiﬁed by anatomic pattern of
joint involvement against publically-available controls.
Results: In theGWASmeta-analysis carriedout acrossOAcaseswithaxial/
medial femoral head migration vs. all other hip OA cases the most sig-
niﬁcant association was observed for rs754106 in intron 1 of the LRCH1
gene (for allele T OR[CIs]¼1.46[1.26-1.68]; p¼2.9x10-7). Adjustment for
genderdidnot attenuate the signal (p¼5.7x10-6). Evidence for association
was strong and consistent across bothGWASsetsdespite the small sample
size of the second study (p¼1.1x10-5, N¼425/1392; p¼0.004, N¼76/225).
Conversely in the GWAS meta-analysis carried out across OA cases with
superior femoral head migration vs. the rest (N¼1469/647) rs754106 is
also the most signiﬁcant locus (p¼1.1x10-7) but the T allele is protective
(OR¼0.7). In the association analysis of hip OA patients with axial/medial
femoral head migration vs population-based controls we still ﬁnd strong
evidence for association at rs754106 (p¼0.00015, OR 1.31[1.13-1.5]) but
when we analyse all hip OA cases together vs. the same control set the
signal is fully attenuated (p¼ 0.89).
Rs754106 is in intron 1 of Leucine-Rich Repeats And Calponin Homology
(CH) Domain Containing 1 (LRCH1/CHDC1) gene. Genetic associations
with knee OA at variants spanning intron 1 of LRCH1 were previously
reported but the most signiﬁcant association was observed at rs912428
(for allele T OR[CIs]¼1.44[1.18-1.79]; p<5x10-4, N¼1978/1798) which is
located 15kb away from rs754106 (D’¼1, r2¼0.242). Similar trends in
allele frequencies were observed for samples with hand and hip OA but
were not signiﬁcant. Subsequent publications examining the role of this
variant in knee or hip OA yielded conﬂicting results while a synthesis of
genetic association studies to date reported an OR of 1.17 with nominal
signiﬁcance and moderate heterogeneity. Our ﬁndings indicate that the
paucity of replication at this locus stems from the differences between
prevalence of pattern of joint involvement in the different cohorts.
Conclusions: By partitioning the hip OA phenotype according to speciﬁc
anatomic pattern of joint involvement we detect a common variant in
LRCH1 and highlight the structural role of this gene in OA. We conclude
that in a highly heterogeneous disease like OA precise phenotype deﬁ-
nition is crucial for empowering the detection and replication of OA
susceptibility loci and can provide important insights into the speciﬁc
processes of OA.
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JOINT RELATED NEUROPATHIC PAIN IS ASSOCIATED WITH LOSS OF
JOINT SPECIFIC FUNCTION AND QUALITY OF LIFE WITHIN HIP AND
KNEE OSTEOARTHRITIS PATIENTS
T. Blikman y, W. Rienstra y, R. Kuilman y, B. Dijkstra z, J.J. van Raay x,
S.K. Bulstra y, I. van den Akker-Scheek y, M. Stevens y. yUniv. Med. Ctr.
Groningen, Groningen, Netherlands; zMed. Ctr. Leeuwarden,
Leeuwarden, Netherlands; xMartini Hosp. Groningen, Groningen,
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Purpose: In the past decade it became clear that Osteoarthritis (OA)-pain
is not solely nociceptive-driven. Changes within the peripheral and
central nervous system are probably accountable for accessory pain
ampliﬁcation and sensitization. It is believed that central sensitisation
(CS) in combination with peripheral nerve disruption may manifest in
OA-painwith neuropathic features. Based on previous studies it’s known
that about 20-37% of the hip/knee OA patients possess a possible or likely
neuropathic pain (NP) phenotype (painDETECT-score >12). As known,
